We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

05 Aug 2026 - 07 Aug 2026
18 Aug 2026 - 20 Aug 2026

Mixed Verdict on Boston Scientific Patents

By HospiMedica staff writers
Posted on 18 Dec 2000
Boston Scientific Corp. More...
(Natick, MA, USA) has announced that a jury in a patent infringement case involving the company's NIR stent, brought by Johnson & Johnson (J&J, New Brunswick, NJ, USA), has ruled in Boston Scientific's favor on three of the four patents at issue. The jury ruled in Boston Scientific's favor on five of the six claims at issue. The jury found that Boston Scientific infringed only one valid claim.

"We hope to persuade the judge to set aside the lone finding of infringement,” said Jim Tobin, president and CEO of Boston Scientific. "We will also present evidence in a separate hearing that these patents were improperly obtained by J&J and should therefore be unenforceable.”

The NIR stent with its multicellular design was developed and is manufactured by Medinol, Ltd. (Jerusalem, Israel). Boston Scientific has an exclusive worldwide license to market and distribute the NIR stent.



Related Links:
Boston Scientific

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Multi-Chamber Washer-Disinfector
WD 390
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image Credit: 123RF

Existing Cardiovascular Risk Calculators Predict Several Common Cancers

Cardiovascular risk calculators are embedded in primary and secondary care to estimate 10‑year risk of heart attack or stroke from factors such as age, body mass index, and smoking. Many of these same... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.